The role of autophagy in ossification of the human ligamentum
flavum

doi:10.3969/j.issn.2095-4344.2497

Abstract

Abstract:

BACKGROUND: Pathological mechanism of ossification of the ligamentum flavum is unclear. There is no effective drug or non-surgical treatment in clinical practice. Current studies have found that osteopontin and autophagy play an important role in the process of osteogenesis, but their role in ossification of the ligamentum flavum has not been elucidated.

OBJECTIVE: To seek for the potential target of drug therapy by exploring the mechanism of ossification of the ligamentum flavum.

METHODS: (1) Surgical specimens of the ligamentum flavum were taken from patients with ossification of the ligamentum flavum, thoracic vertebrae or simple lumbar disc herniation undergoing posterior total laminectomy and decompression. These specimens were divided into two groups: an ossification group and a non-ossification group. Eight specimens from each group were collected. Osteopontin, osteocalcin and autophagy indexes Beclin-1, LC3 and P62 were stained by immunohistochemistry. (2) The ligamentum flavum cells were isolated and cultured by adherence method. The third generation cells were treated with osteopontin at different concentrations for different time to construct an in vitro model of ligamentum flavum ossification. (3) Autophagy inhibitor 3-methyladenine with different concentrations was used to intervene with non-ossified ligamentum flavum cells, followed by induction with 100 μg/L osteopontin. Western blot assay was used to detect the expression of alkaline phosphatase, osteocalcin. (4) Non-ossified ligamentum flavum cells were induced with 100 μg/L osteopontin, and the induction was terminated at 0, 15, 30, 60, and 120 minutes, respectively. The phosphorylation of ERK1/2, JNK and P38, which are important molecules in the MAPK signaling pathway, was detected by western blot. (5) Finally, after inhibition by ERK1/2 phosphorylation blocker U0126, the expression of alkaline phosphatase and osteocalcin was detected by western blot after induction with 100 μg/L steopontin.

RESULTS AND CONCLUSION: (1) Immunohistochemical staining of osteopontin and osteocalcin in ossified and non-ossified ligamentum flavum was positive. In the ossified ligamentum flavum, Beclin-1 was positive, but LC3 and P62 were not. Beclin-1, LC3 and P62 were all positive in the non-ossified ligamentum flavum. (2) The expression of alkaline phosphatase and osteocalcin in the ossified ligamentum flavum cells was higher than that in the non-ossified ligamentum flavum cells. Osteopontin could induce ossification of the ligamentum flavum in a concentration- and time-dependent manner. (3) The degree of ossification was negatively correlated with the degree of autophagy, that is, the more obvious autophagy was, the weaker ossification was. (4) Osteopontin could phosphorylate the MAPK signaling pathway in a time-dependent manner. After inhibiting the phosphorylation of MAPK, osteopontin could still induce the ossification of ligamentum flavum cells. To conclude, in the process of ligamentum flavum ossification, the upstream and downstream relationships of ERK1/2, osteopontin, alkaline phosphatase and osteocalcin molecules in signaling pathway are ERK1/2→osteopontin→osteocalcin /alkaline phosphatase.

Key words: tissue construction, tissue engineering, ossification of the ligamentum flavum, osteopontin, autophagy, signaling pathway, ligamentum flavum, National Natural Science Foundation of China

CLC Number:

Xu Guofeng, Li Xuebin, Tang Yifan, Zhao Yin, Zhou Shengyuan, Chen Xiongsheng, Jia Lianshun. The role of autophagy in ossification of the human ligamentum flavum[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(8): 1174-1181.

Figures/Tables 7

References

[1] EPSTEIN NE. Ossification of the yellow ligament and spondylosis and/or ossification of the posterior longitudinal ligament of the thoracic and lumbar spine. J Spinal Disord. 1999;12(3):250-256.
[2] GUO JJ, LUK KD, KARPPINEN J, et al. Prevalence, distribution, and morphology of ossification of the ligamentum flavum: a population study of one thousand seven hundred thirty-six magnetic resonance imaging scans. Spine (Phila Pa 1976). 2010;35(1):51-56.
[3] INAMASU J, GUIOT BH. A review of factors predictive of surgical outcome for ossification of the ligamentum flavum of the thoracic spine. J Neurosurg Spine. 2006;5(2):133-139.
[4] QU X, CHEN Z, FAN D, et al. Notch signaling pathways in human thoracic ossification of the ligamentum flavum. J Orthop Res. 2016;34(8):1481-1491.
[5] JUNAID A, MOON MC, HARDING GE, et al. Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1. Am J Physiol Cell Physiol. 2007;292(2): C919-926.
[6] MORINOBU M, ISHIJIMA M, RITTLING SR, et al. Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo. J Bone Miner Res. 2003;18(9):1706-1715.
[7] BOULEFTOUR W, BOUET G, GRANITO RN, et al. Blocking the expression of both bone sialoprotein (BSP) and osteopontin (OPN) impairs the anabolic action of PTH in mouse calvaria bone. J Cell Physiol. 2015;230(3):568-577.
[8] WONGKHANTEE S, YONGCHAITRAKUL T, PAVASANT P. Mechanical stress induces osteopontin expression in human periodontal ligament cells through rho kinase. J Periodontol. 2007;78(6):1113-1119.
[9] ZAHM AM, BOHENSKY J, ADAMS CS, et al. Bone cell autophagy is regulated by environmental factors. Cells Tissues Organs. 2011;194(2-4):274-278.
[10] DANCOURT J, MELIA TJ. Lipidation of the autophagy proteins LC3 and GABARAP is a membrane-curvature dependent process. Autophagy. 2014;10(8):1470-1471.
[11] YANG Z, KLIONSKY DJ. An overview of the molecular mechanism of autophagy. Curr Top Microbiol Immunol. 2009; 335:1-32.
[12] BARTH S, GLICK D, MACLEOD KF. Autophagy: assays and artifacts. J Pathol. 2010;221(2):117-124.
[13] MIZUSHIMA N, YOSHIMORI T, LEVINE B. Methods in mammalian autophagy research. Cell. 2010;140(3):313-326.
[14] KLIONSKY DJ, EMR SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290(5497):1717-1721.
[15] FURUYA N, YU J, BYFIELD M, et al. The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy. 2005; 1(1):46-52.
[16] INOUE H, SEICHI A, KIMURA A, et al. Multiple-level ossification of the ligamentum flavum in the cervical spine combined with calcification of the cervical ligamentum flavum and posterior atlanto-axial membrane. Eur Spine J. 2013;22 Suppl 3:S416-20.
[17] 李学斌,许政,周盛源,等.丝裂原活化蛋白激酶信号通路在骨桥蛋白介导黄韧带骨化中的作用[J].中国组织工程研究, 2017, 21(28):4469-4474.
[18] FAN D, CHEN Z, CHEN Y, et al. Mechanistic roles of leptin in osteogenic stimulation in thoracic ligament flavum cells. J Biol Chem. 2007;282(41):29958-29966.
[19] CAI HX, YAYAMA T, UCHIDA K, et al. Cyclic tensile strain facilitates the ossification of ligamentum flavum through β-catenin signaling pathway: in vitro analysis. Spine (Phila Pa 1976). 2012;37(11):E639-646.
[20] MIKAWA Y, HAMAGAMI H, SHIKATA J, et al. Elastin in the human intervertebral disk. A histological and biochemical study comparing it with elastin in the human yellow ligament. Arch Orthop Trauma Surg. 1986;105(6):343-349.
[21] ZAKI SM. Study of the human ligamentum flavum in old age: a histological and morphometric study. Folia Morphol (Warsz). 2014;73(4):492-499.
[22] SHUNZHI Y, ZHONGHAI L, NING Y. Mechanical stress affects the osteogenic differentiation of human ligamentum flavum cells via the BMP‑Smad1 signaling pathway. Mol Med Rep. 2017;16(5):7692-7698.
[23] YANG X, CHEN Z, MENG X, et al. Angiopoietin-2 promotes osteogenic differentiation of thoracic ligamentum flavum cells via modulating the Notch signaling pathway. PLoS One. 2018; 13(12):e0209300.
[24] CHAO YH, HUANG SY, YANG RC, et al. Tissue transglutaminase is involved in mechanical load-induced osteogenic differentiation of human ligamentum flavum cells. Connect Tissue Res. 2016;57(4):307-318.
[25] NING S, CHEN Z, FAN D, et al. Genetic differences in osteogenic differentiation potency in the thoracic ossification of the ligamentum flavum under cyclic mechanical stress. Int J Mol Med. 2017;39(1):135-143.
[26] SAIRYO K, BIYANI A, GOEL V, et al. Pathomechanism of ligamentum flavum hypertrophy: a multidisciplinary investigation based on clinical, biomechanical, histologic, and biologic assessments. Spine (Phila Pa 1976). 2005;30(23): 2649-2656.
[27] YIN X, CHEN Z, GUO Z, et al. Tissue transglutaminase expression and activity in human ligamentum flavum cells derived from thoracic ossification of ligamentum flavum. Spine (Phila Pa 1976). 2010;35(20):E1018-1024.
[28] LIU Y, ZHAO Y, CHEN Y, et al. RUNX2 polymorphisms associated with OPLL and OLF in the Han population. Clin Orthop Relat Res. 2010;468(12):3333-3341.
[29] ZHONG ZM, CHEN JT, ZHANG Y, et al. Growth/differentiation factor-5 induces osteogenic differentiation of human ligamentum flavum cells through activation of ERK1/2 and p38 MAPK. Cell Physiol Biochem. 2010;26(2):179-186.
[30] ZHANG C, CHEN Z, MENG X, et al. The involvement and possible mechanism of pro-inflammatory tumor necrosis factor alpha (TNF-α) in thoracic ossification of the ligamentum flavum. PLoS One. 2017;12(6):e0178986.
[31] 杨晓曦,陈仲强.胸椎黄韧带骨化易感基因及蛋白质组学研究进展[J].中国脊柱脊髓杂志,2018,28(6):562-566.
[32] YAYAMA T, MORI K, OKUMURA N, et al. Wnt signaling pathway correlates with ossification of the spinal ligament: A microRNA array and immunohistochemical study. J Orthop Sci. 2018;23(1):26-31.
[33] YIN J, ZHUANG G, ZHU Y, et al. MiR-615-3p inhibits the osteogenic differentiation of human lumbar ligamentum flavum cells via suppression of osteogenic regulators GDF5 and FOXO1. Cell Biol Int. 2017;41(7):779-786.
[34] QU X, CHEN Z, FAN D, et al. MiR-199b-5p inhibits osteogenic differentiation in ligamentum flavum cells by targeting JAG1 and modulating the Notch signalling pathway. J Cell Mol Med. 2017;21(6):1159-1170.
[35] QU X, CHEN Z, FAN D, et al. Notch signaling pathways in human thoracic ossification of the ligamentum flavum. J Orthop Res. 2016;34(8):1481-1491.
[36] BOULEFTOUR W, BOUET G, GRANITO RN, et al. Blocking the expression of both bone sialoprotein (BSP) and osteopontin (OPN) impairs the anabolic action of PTH in mouse calvaria bone. J Cell Physiol. 2015;230(3):568-577.
[37] CHEN Q, SHOU P, ZHANG L, et al. An osteopontin-integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells. Stem Cells. 2014; 32(2):327-337.
[38] INOUE M, SHINOHARA ML. Intracellular osteopontin (iOPN) and immunity. Immunol Res. 2011;49(1-3):160-172.
[39] RANGASWAMI H, BULBULE A, KUNDU GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol. 2006;16(2):79-87.
[40] CHEN Q, SHOU P, ZHANG L, et al. An osteopontin-integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells. Stem Cells. 2014; 32(2):327-337.
[41] 许政,周盛源,李学斌,等.骨桥蛋白及其受体在黄韧带骨化症黄韧带细胞中的表达及其意义[J].中国组织工程研究,2016,20(2): 179-184.
[42] FRANZÉN A, HEINEGÅRD D. Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J. 1985;232(3):715-724.
[43] HIROTA S, ASADA H, KOHRI K, et al. Possible role of osteopontin in deposition of calcium phosphate in human pilomatricomas. J Invest Dermatol. 1995;105(1):138-142.
[44] WONGKHANTEE S, YONGCHAITRAKUL T, PAVASANT P. Mechanical stress induces osteopontin expression in human periodontal ligament cells through rho kinase. J Periodontol. 2007;78(6):1113-1119.
[45] SODEK KL, TUPY JH, SODEK J, et al. Relationships between bone protein and mineral in developing porcine long bone and calvaria. Bone. 2000;26(2):189-198.
[46] 杨戈,林迭生,练克俭.自噬与骨组织及骨类疾病[J].国际骨科学杂志,2014,35 (3):181-183.
[47] KIM KH, LEE MS. Autophagy--a key player in cellular and body metabolism. Nat Rev Endocrinol. 2014;10(6):322-337.
[48] CARAMÉS B, HASEGAWA A, TANIGUCHI N, et al. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Ann Rheum Dis. 2012;71(4): 575-581.
[49] JU JS, WEIHL CC. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy. Hum Mol Genet. 2010;19(R1):R38-45.
[50] HOCKING LJ, WHITEHOUSE C, HELFRICH MH. Autophagy: a new player in skeletal maintenance?J Bone Miner Res. 2012; 27(7):1439-1447.
[51] ZHAO H,XIONG J,ONAL M,et al. Osteocyte autophagy declines with age in mice and suppression of autophagy decreases bone mass. J Bone Min Res. 2012;26(Abstract): 1039.
[52] DAI JP, ZHAO XF, ZENG J, et al. Drug screening for autophagy inhibitors based on the dissociation of Beclin1-Bcl2 complex using BiFC technique and mechanism of eugenol on anti-influenza A virus activity. PLoS One. 2013; 8(4):e61026.
[53] KIM JH, HONG SK, WU PK, et al. Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels. Exp Cell Res. 2014;327(2):340-352.
[54] SIVAPRASAD U, BASU A. Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells. J Cell Mol Med. 2008;12(4):1265-1271.
[55] NI BB, LI B, YANG YH, et al. The effect of transforming growth factor β1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation. Cytokine. 2014;70(2):87-96.